Scientists have developed a 3D-printed implant that delivers targeted electrical stimulation to damaged areas of the spinal ...

Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple sclerosis.

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins ...

A paralyzed United States military veteran has been implanted with the ground-breaking Neuralink brain-computer device by ...

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy. Two phase 3 studies are currently underway testing riliprubart in peopl ...

Japanese MHLW grants orphan drug designation to Sanofi’s riliprubart for chronic inflammatory demyelinating polyneuropathy: Paris Tuesday, July 1, 2025, 09:00 Hrs [IST] The Mini ...

Paris: Sanofi has received orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW) in Japan for riliprubart, a monoclonal antibody that selectively inhibits activated C1s ...

In a nutshell Scientists used magnetic brain stimulation to restore damaged connections in mice with Alzheimer’s-like symptoms, essentially “rescuing” their brain flexibility to healthy levels. The ...